IL6 and medical procedure: Lipopolysaccharide‐induced kidney dysfunction via NF‐κB and MAPK activation, by excessive production of IL‐6, TNF‐α, iNOS, and COX‐2, producing perturbance in energy metabolism and oxidative stress.